Sibbald, B. (2002). US estrogen plus progestin HRT trial stopped due to increased risk of breast cancer, stroke and heart attack.
Styl cytowania ChicagoSibbald, Barbara. US Estrogen Plus Progestin HRT Trial Stopped Due to Increased Risk of Breast Cancer, Stroke and Heart Attack. 2002.
Styl cytowania MLASibbald, Barbara. US Estrogen Plus Progestin HRT Trial Stopped Due to Increased Risk of Breast Cancer, Stroke and Heart Attack. 2002.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..